title: Functional characterization of rhesus embryonic stem cell-derived serotonin neurons.
abstract: Optimal function of the serotonin system is essential for mental health and its role in psychopathologies is undisputed. Enhancing the ability to study primate serotonin neurons in culture would facilitate understanding of intracellular signaling pathways that mediate the action of drugs and other epigenetic or developmental factors impacting human mental health. We were the first group to report differentiation of the non-human primate rhesus monkey embryonic stem cell (ESC) line 366.4 into cultures of serotonin neurons. In this study, we optimized yield and obtained functional characteristics of the derived serotonin neurons. Sequential treatments of ESC 366.4 during expansion stage with fibroblast growth factor 4 and sonic hedgehog markedly increased the yield of serotonin neurons. These serotonin neurons propagated action potentials and expressed GABA receptors. Also, for the first time we demonstrate that these ESC-derived serotonin neurons exhibit functional high-affinity transporter sites, as well as high-affinity 5HT(1A) binding sites, which are essential targets of common psychoactive drugs. Finally, to test the generality of this method, we utilized another rhesus ESC line, ORMES-22, which efficiently differentiated into serotonin neurons. Together, these findings demonstrate the feasibility of our protocol to direct different primate ESC lines to serotonin neurons with physiological characteristics, which makes them a useful in vitro model system.
authors.affiliation: Division of Reproductive Sciences, Oregon National Primate Research Center, Beaverton, OR 97006, USA. tokuyama@ohsu.edu
authors.forename: Yukari
authors.initials: Y
authors.lastname: Tokuyama
authors.forename: Susan L
authors.initials: SL
authors.lastname: Ingram
authors.forename: Joy S
authors.initials: JS
authors.lastname: Woodward
authors.forename: Cynthia L
authors.initials: CL
authors.lastname: Bethea
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D053595:Embryonic Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D053823:Hedgehog Proteins / Q000494:pharmacology; D008253:Macaca mulatta; D026901:Membrane Transport Proteins / Q000378:metabolism; D051379:Mice; D008934:Mitogens / Q000494:pharmacology; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D011985:Receptors, Serotonin / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism*
chemical_list: D053823:Hedgehog Proteins; D026901:Membrane Transport Proteins; D008934:Mitogens; D011985:Receptors, Serotonin; D012701:Serotonin
references.citation: J Neurosci. 1998 Sep 15;18(18):7394-401
references.pmid: 9736659
references.citation: Front Neuroendocrinol. 2002 Jan;23(1):41-100
references.pmid: 11906203
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):85-102
references.pmid: 12551730
references.citation: Neuropharmacology. 1997 Apr-May;36(4-5):475-82
references.pmid: 9225272
references.citation: Front Neuroendocrinol. 2009 Jul;30(2):212-38
references.pmid: 19394356
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7844-8
references.pmid: 7544005
references.citation: Neuropsychopharmacology. 1996 Jan;14(1):35-46
references.pmid: 8719028
references.citation: Gene Expr Patterns. 2009 Feb;9(2):94-108
references.pmid: 18996226
references.citation: Nat Biotechnol. 2000 Jun;18(6):675-9
references.pmid: 10835609
references.citation: Brain Res Bull. 2001 Nov 15;56(5):413-24
references.pmid: 11750787
references.citation: J Neurosci. 2003 Nov 5;23(31):9961-7
references.pmid: 14602809
references.citation: J Neurosci. 2001 Sep 1;21(17):6862-73
references.pmid: 11517274
references.citation: Mol Psychiatry. 2003 Mar;8(3):353-60
references.pmid: 12660809
references.citation: Neuroscience. 1994 Dec;63(3):775-87
references.pmid: 7898677
references.citation: Eur J Pharmacol. 1986 Sep 9;128(3):295-8
references.pmid: 2878817
references.citation: Stem Cells. 2006 Oct;24(10):2177-86
references.pmid: 16741224
references.citation: Stem Cells Dev. 2009 May;18(4):615-27
references.pmid: 18800863
references.citation: Exp Neurol. 2004 Aug;188(2):351-64
references.pmid: 15246835
references.citation: Nature. 2002 Jul 4;418(6893):50-6
references.pmid: 12077607
references.citation: Biochem Pharmacol. 2003 Nov 1;66(9):1673-80
references.pmid: 14563478
references.citation: Nature. 1981 Jul 9;292(5819):154-6
references.pmid: 7242681
references.citation: Neuron. 2003 Jan 23;37(2):233-47
references.pmid: 12546819
references.citation: Mol Interv. 2004 Apr;4(2):109-23
references.pmid: 15087484
references.citation: Neuropsychopharmacology. 2002 Jul;27(1):12-24
references.pmid: 12062903
references.citation: Nat Biotechnol. 2003 Oct;21(10):1200-7
references.pmid: 14502203
references.citation: Neurochem Res. 2008 Nov;33(11):2250-6
references.pmid: 18437564
references.citation: Nature. 2002 Mar 28;416(6879):396-400
references.pmid: 11919622
references.citation: Synapse. 1987;1(5):470-80
references.pmid: 2905533
references.citation: Arch Gen Psychiatry. 1994 Mar;51(3):248-51
references.pmid: 8122960